AG7-18330-18773
3 vaccinations
11 coded responses
42 check-ins
11 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 906 / CA
- Registered
- 2021-03-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-15
Registered in v-safe
-
2021-03-15
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-15
Survey response — day 0, dose 1MedDRA: Dizziness, Hypoaesthesia — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Numbness of hand and foot, dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-16
Survey response — days 1–6 daily, dose 1MedDRA: Back pain, Chest discomfort, Hypoaesthesia, Wheezing — Feeling: Poor · Site: Pain, Redness, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Wheezing, chest tightness, numbness of right side of face, back painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-16
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-17
Survey response — days 1–6 daily, dose 1MedDRA: Injection site erythema, Injection site pain, Injection site swelling, Tongue geographic, Wheezing — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesFree text: Swelling, redness, and tenderness on injection site, geographic tongue, wheezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Survey response — days 1–6 daily, dose 1MedDRA: Tongue geographic — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Geographic tongueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-20
Survey response — days 1–6 daily, dose 1MedDRA: Injection site warmth — Feeling: Fair · Site: Pain, Redness, Swelling, ItchingFree text: Injection site is warm to the touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — days 1–6 daily, dose 1MedDRA: Vaccination site warmth — Feeling: Good · Site: Pain, Redness, SwellingFree text: Vaccine site is warm to touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Survey response — day 7, dose 1MedDRA: Injection site induration, Injection site warmth — Feeling: Good · Site: Pain, Redness, Swelling, ItchingFree text: Injection site hard and warm to touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-29
- 2021-04-06
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-06
- 2021-06-14
- 2021-09-13
-
2022-01-21
Dose 2 — Moderna
-
2022-01-21
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2022-01-22
Report sent to call center — days 1–6 daily, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2022-01-24
-
2022-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tirednessAdult check-in
- 2022-01-27
- 2022-01-28
- 2022-02-04
- 2022-02-11
- 2022-02-18
- 2022-02-25
-
2022-03-04
Survey response — day 42, dose 2MedDRA: Hypersensitivity — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Allergic reaction to a vaccine.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-04
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-07
- 2022-04-22
- 2022-07-22
-
2022-11-18
Dose 3 — Moderna
-
2022-11-19
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-11-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-11-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2022-11-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Fatigue or tiredness, Abdominal painAdult check-in
- 2022-11-25
-
2022-12-02
Survey response — day 14, dose 3MedDRA: Asthma, Pre-existing disease, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sinus infection and exacerbation of my asthma.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Report sent to call center — day 14, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-05
- 2022-12-05
- 2022-12-05
- 2022-12-05
- 2022-12-05
- 2022-12-05
- 2022-12-11
-
2022-12-16
Survey response — day 28, dose 3MedDRA: Asthma — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: AsthmaMedDRA releases: 2024-11 · check-in free text available
-
2022-12-16
Report sent to call center — day 28, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-19
- 2022-12-19
- 2022-12-19
- 2022-12-19
-
2022-12-23
Survey response — day 35, dose 3MedDRA: Bronchitis, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Bronchitis from a URIMedDRA releases: 2024-11 · check-in free text available
-
2022-12-23
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-27
- 2022-12-27
- 2022-12-27
- 2022-12-27
- 2022-12-27
- 2022-12-27
- 2022-12-30
- 2023-02-17
- 2023-05-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Janssen/Johnson & Johnson | |
| 2 | 2022-01-21 | Moderna | No |
| 3 | 2022-11-18 | Moderna | No |
Call center
6 call center cases
6 unsuccessful
VAERS report filed, before or during a call: 1
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Numbness of hand and foot, dizziness
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Wheezing, chest tightness, numbness of right side of face, back pain
Systemic reaction (other): Swelling, redness, and tenderness on injection site, geographic tongue, wheezing
Systemic reaction (other): Geographic tongue
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Injection site is warm to the touch
Systemic reaction (other): Vaccine site is warm to touch
Release 6 — day 7, dose 1
Systemic reaction (other): Injection site hard and warm to touch
Release 11 — day 42, dose 2
Symptoms: Allergic reaction to a vaccine.
Release 12 — day 14, dose 3
Symptoms: Sinus infection and exacerbation of my asthma.
Release 12 — day 28, dose 3
Symptoms: Asthma
Release 12 — day 35, dose 3
Symptoms: Bronchitis from a URI
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Bronchitis | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Back pain | ✓ | ✓ | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site induration | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | Tongue geographic | ✓ | ✓ | ✓ |
| SRO | Vaccination site warmth | ✓ | ✓ | ✓ |
| SRO | Wheezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release